vimarsana.com
Home
Live Updates
Clears Investigational New Drug Application - Breaking News
Pages:
Latest Breaking News On - Clears investigational new drug application - Page 1 : vimarsana.com
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
U.S. Food and Drug Administration Clears Investigational New Drug Application for VERVE-101 in Patients with Heterozygous Familial Hypercholesterolemia Collaboration with Eli Lilly and Company .
New york
United states
City of
United kingdom
New zealand
Sekar kathiresan
Eli lilly
Ashlea kosikowski
Frederick fredt fiedorek
Jen robinson
Verve therapeutics inc
American heart association
Drug administration
Vertex pharmaceuticals incorporated
American heart association scientific sessions
Research development rd expenses
vimarsana © 2020. All Rights Reserved.